SC 13G/A
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
Information to be Included in Statements Filed Pursuant to Rules 13d-1 (b), (c)
and (d) and Amendments Thereto Filed Pursuant To Rule 13d-2.
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Simcere Pharmaceutical Group
 
(Name of Issuer)
Ordinary Shares, par value US$0.01 per share
 
(Title of Class of Securities)
82859P 10 41
 
(CUSIP Number)
December 31, 2008
 
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
  o    Rule 13d-1(b)
 
  o    Rule 13d-1(c)
 
  þ    Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
[Continued on following pages]
 
1   This CUSIP number applies to the Issuer’s American Depositary Shares, each representing two Ordinary Shares.
 
 


TABLE OF CONTENTS

SIGNATURE
EX-99.1


Table of Contents

                     
CUSIP No.
 
82859P 10 4 
  Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS
Assure Ahead Investments Limited
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  British Virgin Islands
       
  5   SOLE VOTING POWER
     
NUMBER OF   17,924,692 Ordinary Shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   17,924,692 Ordinary Shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  17,924,692 Ordinary Shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  14.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO


Table of Contents

                     
CUSIP No.
 
82859P 10 4 
  Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS
Hony Capital II, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Cayman Islands
       
  5   SOLE VOTING POWER
     
NUMBER OF   17,924,692 Ordinary Shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   17,924,692 Ordinary Shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  17,924,692 Ordinary Shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  14.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN


Table of Contents

                     
CUSIP No.
 
82859P 10 4 
  Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS
Hony Capital II GP Ltd.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Cayman Islands
       
  5   SOLE VOTING POWER
     
NUMBER OF   17,924,692 Ordinary Shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   17,924,692 Ordinary Shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  17,924,692 Ordinary Shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  14.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO


Table of Contents

CUSIP NO. 82859P 10 4   Schedule 13G   Page 5 of 8 Pages
     
ITEM 1(a).
  NAME OF ISSUER:
 
   
 
  Simcere Pharmaceutical Group (the “Issuer”)
 
   
ITEM 1(b).
  ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
 
   
 
  No. 699-18 Xuan Wu Avenue
 
  Xuan Wu District, Nanjing
 
  Jiangsu Province 210042
 
  People’s Republic of China
 
   
ITEM 2(a).
  NAME OF PERSON FILING:
 
   
 
  This Schedule 13G is filed by and on behalf of (a) Assure Ahead Investments Limited, (b) Hony Capital II, L.P. and (c) Hony Capital II GP Ltd. Hony Capital II, L.P. holds all equity interest in Assure Ahead Investments Limited and has the right to appoint and remove all directors of Assure Ahead Investments Limited. Pursuant to Rule 13d-3 under the Act, Hony Capital II, L.P. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuer owned by Assure Ahead Investments Limited. Hony Capital II GP Ltd. is the general partner of Hony Capital II, L.P. Pursuant to Rule 13d-3 under the Act, Hony Capital II GP Ltd. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuers beneficially owned by Hony Capital II, L.P. Assure Ahead Investments Limited, Hony Capital II, L.P. and Hony Capital II GP Ltd. are making this single, joint filing pursuant to Rule 13d-1(k) of the Act because each of them is reporting as to the beneficial ownership of the same securities.
 
   
ITEM 2(b).
  ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:
 
   
 
  The address of principal business office of each of Assure Ahead Investments Limited, Hony Capital II, L.P. and Hony Capital II GP Ltd. is 6th Floor, South Tower C, Raycom InfoTech Park, No.2 Kexueyuan Nanlu, Haidian District, Beijing 100080, the People’s Republic of China
 
   
ITEM 2(c)
  CITIZENSHIP:
 
   
 
  Assure Ahead Investments Limited is a British Virgin Islands company. Hony Capital II, L.P. and Hony Capital II GP Ltd. are chartered in the Cayman Islands.

 


Table of Contents

CUSIP NO. 82859P 10 4   Schedule 13G   Page 6 of 8 Pages
     
ITEM 2(d).
  TITLE OF CLASS OF SECURITIES:
 
   
 
  Ordinary Shares
 
   
ITEM 2(e).
  CUSIP NUMBER:
 
   
 
  82859P 10 4
 
   
ITEM 3.
  STATEMENT FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) or (c):
 
   
 
  Not applicable.
 
   
ITEM 4.
  OWNERSHIP.
 
   
 
  The following information with respect to the ownership of the Ordinary Shares of the Issuer by the persons filing this statement is provided as of December 31, 2008. The percentage amounts are based on 124,040,898 Ordinary Shares outstanding as of December 31, 2008, as derived from the Issuer’s corporate records.
                         
            Number of shares as to which the person has:
                    Sole power   Shared
            Sole   Shared   to dispose   power to
            power to   power to   or to   dispose or
    Amount       vote or   vote or   direct the   to direct the
    beneficially   Percent   to direct   to direct   disposition   disposition
Reporting Person   owned:   of class:   the vote:   the vote:   of:   of:
Assure Ahead Investments Limited
  17,924,692   14.5%   17,924,692     17,924,692  
 
                       
Hony Capital II, L.P.
  17,924,692   14.5%   17,924,692     17,924,692  
 
                       
Hony Capital II GP Ltd.
  17,924,692   14.5%   17,924,692     17,924,692  
     
 
   
 
  Assure Ahead Investments Limited is the record holder of 17,924,692 Ordinary Shares of the Issuer. Hony Capital II, L.P. holds all equity interest in Assure Ahead Investments Limited and has the right to appoint and remove all directors of Assure Ahead Investments Limited. Pursuant to Rule 13d-3 under the Act, Hony Capital II, L.P. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuer owned by Assure Ahead Investments Limited. Hony Capital II GP Ltd. is the general partner of Hony Capital II, L.P. Pursuant to Rule 13d-3 under the Act, Hony Capital II GP Ltd. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuers beneficially owned by Hony Capital II, L.P.
 
   
ITEM 5.
  OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
 
   
 
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: o

 


Table of Contents

CUSIP NO. 82859P 10 4   Schedule 13G   Page 7 of 8 Pages
     
ITEM 6.
  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
 
   
 
  Not applicable
 
   
ITEM 7.
  IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
 
   
 
  Hony Capital II, L.P. holds all equity interest in Assure Ahead Investments Limited. Hony Capital II GP Ltd. holds a general partnership interest in Hony Capital II, L.P.
 
   
ITEM 8.
  IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
 
   
 
  Not applicable
 
   
ITEM 9.
  NOTICE OF DISSOLUTION OF GROUP.
 
   
 
  Not applicable
 
ITEM 10.
  CERTIFICATION.
 
 
  Not applicable

 


Table of Contents

CUSIP NO. 82859P 10 4   Schedule 13G   Page 8 of 8 Pages
SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 13, 2009
         
  Assure Ahead Investments Limited
 
 
  By:   /s/ Yonggang Cao    
    Yonggang Cao   
    Director   
 
  Hony Capital II, L.P.
Acting by its general partner
Hony Capital II GP Ltd.
 
 
  By:   /s/ John Huan Zhao    
    John Huan Zhao   
    a duly authorized representative   
 
  Hony Capital II GP LTD.
 
 
  By:   /s/ John Huan Zhao    
    John Huan Zhao   
    Director